China Pharma Holding (STU:XQJ0) 3-Year EBITDA Growth Rate : -74.70% (As of Mar. 2024)

View and export this data going back to 2009. Start your Free Trial

What is China Pharma Holding 3-Year EBITDA Growth Rate?

China Pharma Holding's EBITDA per Share for the three months ended in Mar. 2024 was €-0.01.

During the past 3 years, the average EBITDA Per Share Growth Rate was -74.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of China Pharma Holding was 65.90% per year. The lowest was -74.70% per year. And the median was 7.60% per year.

Competitive Comparison of China Pharma Holding's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, China Pharma Holding's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

China Pharma Holding's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, China Pharma Holding's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where China Pharma Holding's 3-Year EBITDA Growth Rate falls into.

China Pharma Holding 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

China Pharma Holding (STU:XQJ0) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

China Pharma Holding 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of China Pharma Holding's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

China Pharma Holding (STU:XQJ0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Pharma Holding Inc (STU:XQJ0) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

CPHI:USA

Address

Second Floor, No. 17, Jinpan Road, Hainan Province, Haikou, CHN, 570216

Website

https://www.chinapharmaholdings.com

China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection, and others.

China Pharma Holding (STU:XQJ0) Headlines

No Headlines